Enhance clinical productivity and improve population health outcomes by identifying risks, detecting rare diseases and tracking disease progression with CLiX® unlock enterprise.
Health systems face an ever-growing demand for services, rising operational costs and a workforce struggling with burnout. Generating high-fidelity clinical insights for targeted interventions to help address these challenges is crucially important, and no longer optional.
Clinithink's proven CLiX technology utilises the power of SNOMED CT and it’s unique terminology query engine to describe complex clinical concepts as actionable features.
It's ability to read and interpret thousands of documents in seconds and extract critical information helps identify patients within very large populations, often much earlier in the disease process. Thereby relieving the pressure on frontline teams, and freeing them up to focus on delivering clinical care.
This makes CLiX unlock enterprise well suited to difficult tasks such as monitoring the progression of physical and mental health issues, detection of rare diseases and monitoring data across large populations.
Our customers and partners are utilising the power of CLiX unlock enterprise to improve health outcomes and reduce healthcare costs, by identifying patients most at risk of serious disease, diagnosing rare diseases, and prioritising patients for earlier interventions.
Clinithink's patented CLiX technology empowers healthcare organisations to take a more proactive approach to population health management to deliver more sustainable and targeted interventions, better focused on prevention.
Find at-risk patient groups rapidly from within large populations, without extensive manual review